Immunity, inflammation and cancer

Summary

Our group is focused on three research lines. Regarding the exonuclease TREX2, our studies have been pioneering in unraveling the specific expression of TREX2 in keratinocytes and its key role in skin carcinogenesis and psoriasis. We also study how chromatin factors integrate extracellular signals into the nucleus to regulate gene expression and ultimately, influence cell fate and behavior. Our aim is to understand chromatin dynamics in cancer disease to find novel therapeutic interventions. Concerning oncolytic vaccinia viruses (VACV), our group is focused on improving their capacity to generate robust antitumor immune responses through an activation of an Immunogenic Cancer Cell Death (ICD) after infection. In addition, combination of these agents with other cancer immunotherapies are also explored in order to achieve a combinatory immunotherapy with a real potential to cure solid tumors.

107

Publications

Immunity-inflammation-and-cancer
Concepció-Soler22

Soler Prat, Concepció

Principal investigators

Concepció-Soler22

Soler Prat, Concepció

Sonia-Vanina-Forcales

Forcales Fernández, Sonia Vanina

Juanjo-Rojas

Rojas Expósito, Juan José

SONY DSC

Manils Pacheco, Joan

Team

Group leaders
  • Soler Prat, Concepció
Principal Investigators
Predoctoral researchers
Scroll to Top